Comments on SCCR/48/3 March 18, 2026 WIPO Broadcast Treaty Text
KEI Briefing Note
U.S. legislative proposals requesting the National Academies study feasibility and benefits of de-linking pharmaceutical innovation from drug prices
U.S. legislative proposals requesting the National Academies study feasibility and benefits of delinking pharmaceutical innovation from drug prices KEI Briefing Note 2026:3 May 4, 2026 Zazie Huml KEI-BN-2026-3 Several members of Congress have asked the U.S. National Academies to study… Continue Reading
Including language on traditional knowledge in the PABS Annex introduces unrelated and complex issues that lack consensus or clear implementation standards
Contracts that Restrict Patent Filing or Impose Patent-Licensing Obligations
Contracts that restrict patent filing or impose patent-licensing obligations This briefing note illustrates examples of contractual language from data-sharing agreements and material transfer agreements that limit patent filing or impose specific licensing terms. KEI Briefing Note 2025:4 Arianna Schouten December… Continue Reading
Note on Liability Rules
Selected Documents Prepared by the WIPO Secretariat for the Intergovernmental Committee (IGC) on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore
KEI Comments on NIH Proposal to Require License Holders to Provide Access Plans
KEI Comments to CMS Regarding Imbruvica (INN:Ibrutinib) R&D (regarding Medicare pricing negotiations)
On October 2, 2023, Knowledge Ecology International submitted written comments to the Centers for Medicare & Medicaid Services (CMS) in conjunction with the Medicare Price Negotiation public consultation process. CMS is hosting a series of patient-focused listening sessions this fall,… Continue Reading
KEI Notes on the Clinical Studies for Imbruvica (Ibrutinib)
Notes on the Preclinical Development of Imbruvica (Ibrutinib)